^
    1year
    Implementation and Outcomes of a Universal Germline Screening Program in a Community Urology Practice (AUA 2023)
    Genetic risk assessment for high-risk individuals is feasible as part of a universal screening program in a community urology practice. Approximately 12% of tested patients were found to have pathogenic germline mutations, which is consistent with contemporary tertiary referral cohorts.
    BRCA Biomarker
    |
    BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • CHEK2 (Checkpoint kinase 2) • NBN (Nibrin Nijmegen Breakage Syndrome 1 (Nibrin)) • LZTR1 (Leucine Zipper Like Transcription Regulator 1)
    |
    BRCA1 mutation • CHEK2 mutation • NBN mutation
    |
    ProstateNext®
    3years
    Early Prostate Cancer: Predicting Treatment Response (clinicaltrials.gov)
    P=N/A; Active, not recruiting --> Recruiting
    Enrollment open
    |
    ProstateNext®